Gary A. Gelbfish, Director at CorMedix Inc. (CRMD), bought 52,083 shares at $0.48 ($25K) on 2017-12-12, disclosed to the SEC on 2017-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.